Compare Repligen Corporation Common Stock (RGEN) vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF (VTIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $49.94 (market cap $73.20B). The key difference: Vanguard Sht-Term Inflation-Protected Sec Idx ETF is far larger — about 6.6× Repligen Corporation Common Stock's market cap, and Vanguard Sht-Term Inflation-Protected Sec Idx ETF is more actively traded (2,410,205 versus 1,259,263). Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Vanguard Sht-Term Inflation-Protected Sec Idx ETF for 92 Days on average.
| RGEN | VTIP | |
|---|---|---|
Market Cap | $11.14B | $73.20B |
Volume | 1,259,263 | 2,410,205 |
Sector | Health | — |
52-Week High | $194.57 | $50.46 |
52-Week Low | $102.87 | $48.38 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $11.02B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
VTIP, a Vanguard short-term inflation-protected securities ETF, trades at $48.46, down 0.06% on the day. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators are neutral. The fund focuses on short-duration TIPS to hedge inflation with minimal interest-rate risk, attracting institutional interest as seen in recent filings. News highlights its role in protecting against inflation spikes and Fed rate hikes.
The outlook for VTIP is supported by persistent inflation and high real yields, offering a defensive allocation. Risks include interest rate volatility and potential underperformance if inflation recedes. Institutional accumulation suggests confidence, but investors should weigh the fund's low sensitivity against broader bond market shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Vanguard Sht-Term Inflation-Protected Sec Idx ETF
The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →
